Filing Details
- Accession Number:
- 0001127602-19-032652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 17:31:46
- Reporting Period:
- 2019-11-11
- Accepted Time:
- 2019-11-13 17:31:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239351 | P Stephen Macmillan | 250 Campus Drive Marlborough MA 01752 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-11 | 194,396 | $22.29 | 1,781,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-11 | 67,440 | $45.44 | 1,714,371 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-11 | 126,956 | $46.16 | 1,587,415 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-11-11 | 21,600 | $22.29 | 1,609,015 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-11 | 33,772 | $0.00 | 1,642,787 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-11-11 | 46,183 | $0.00 | 1,688,970 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2019-11-11 | 21,925 | $0.00 | 1,710,895 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-11-12 | 8,178 | $46.15 | 1,702,717 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-11-11 | 194,396 | $0.00 | 194,396 | $22.29 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2019-11-11 | 21,600 | $0.00 | 21,600 | $22.29 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Acquisiton | 2019-11-11 | 152,529 | $0.00 | 152,529 | $45.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 453,592 | 2014-12-06 | 2020-12-06 | No | 4 | M | Direct |
| 431,992 | 2014-12-06 | 2020-12-06 | No | 4 | M | Direct |
| 152,529 | 2029-11-11 | No | 4 | A | Direct |
Footnotes
- Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019.
- Includes 1,045,901 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $45.265 to $45.92 per share. The Reporting Person will provide, upon request from the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $45.93 to $46.51 per share. The Reporting Person will provide, upon request from the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. Once vested, the settlement of these performance stock units will be deferred pursuant to Issuer's Deferred Equity Plan.
- Performance stock units are settled in shares of common stock on a one-for-one basis.
- Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
- This restricted stock unit award vests in three equal installments beginning on the first anniversary of the grant date, November 11, 2019.
- Restricted stock units are settled in shares of common stock on a one-for-one basis.
- Represents matching restricted stock units granted to the Reporting Person which vest in one installment on the third anniversary of the grant date, November 11, 2019.
- This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 11, 2019.
Billionaire Hedge Funds
